Selperin Capsule 75 mg (Pregabalin)
Pregabalin
Prescription medication
Telcon RF Pharmaceutical Co., Ltd.
MFDS item code 201802045 · Approved 2018.05.14
This product's status changed to Expired on 2023.05.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures
This medication is used to treat peripheral and central neuropathic pain in adults. Additionally, it is utilized as an adjunctive treatment for partial seizures in epilepsy patients regardless of the presence of secondary generalized symptoms. Furthermore, it is effective in alleviating pain in patients with fibromyalgia. This is a medication that helps improve various neurological conditions and pain.
Administer the total daily dose of this medicine, pregabalin, orally in 2 divided doses, regardless of food. As this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See '5. Patients with renal impairment') 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg per day. Based on the response and tolerability of the individual patient, the dose may be increased to 300 mg per day after 3 to 7 days. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg per day. 2) Central neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg per day. Based on the response and tolerability of the individual patient, the dose may be increased to 300 mg per day after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See '4. Discontinuation') 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150 mg per day. Based on the response and tolerability of the individual patient, the dose may be increased to 300 mg per day after 1 week. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg per day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg per day. The initial dose is 75 mg twice daily (150 mg per day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg per day). For patients who do not experience sufficient benefit at a dose of 300 mg per day, the dose may be increased within 1 week to 225 mg twice daily (450 mg per day). Clinical studies have also been conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation Based on current clinical experience, this medicine should be gradually discontinued over a period of at least 1 week when treatment is stopped. 5. Patients with renal impairment This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients receiving hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosing based on renal function Creatinine clearance (CLcr), (mL/min) / Starting dose (mg/day) / Maximum dose (mg/day) / Dosing regimen ≥60 / 150 / 600 / BID or TID ≥30 -<60 / 75 / 300 / BID or TID ≥15 -<30 / 25-50 / 150 / QD or BID <15 / 25 / 75 / QD Supplemental dose after hemodialysis / 25 / 100 / Single dose b TID = Total daily dose administered in 3 divided doses BID = Total daily dose administered in 2 divided doses QD = Administered once daily a: The total daily dose (mg/day) should be administered in divided doses as specified in the dosing regimen. b: A supplemental dose refers to a dose administered once in addition to the regular dose. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Elderly patients (aged 65 years and older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Administration is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12 to 17 years: Administration is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behaviors, so if symptoms of depression or mood changes occur during treatment, consult a physician immediately. Do not take this medication if you have hypersensitivity to it or specific genetic conditions such as lactose intolerance. Diabetes patients should be cautious as they may need to adjust the dosage of blood sugar control medications due to weight gain. If symptoms of angioedema occur, stop taking the medication immediately and inform healthcare personnel. Elderly patients should be cautious when initially taking this medication due to the risk of falls caused by dizziness or drowsiness. If blurred vision or changes in eyesight occur, consult a physician, and the medication may be discontinued if necessary. Discontinuing the medication suddenly can lead to withdrawal symptoms such as insomnia, headaches, and anxiety, so it is advisable to taper off gradually under the guidance of a physician. Due to the potential for drug abuse or dependence, patients with a history of psychiatric disorders should be monitored closely. Patients with compromised kidney function may require dosage adjustments. Patients with heart disease should be cautious when taking this medication. Taking this medication together with opioid analgesics may increase the risk of central nervous system depression, requiring caution. Patients with weak respiratory function or the elderly may have an increased risk of severe respiratory depression, necessitating careful attention. Pregnant women should avoid this medication during early pregnancy due to the risk of fetal malformation, and women of childbearing age should use effective contraception. Lactating women should consult a physician about discontinuing breastfeeding or the medication as it may be transferred through breast milk. Before driving or operating dangerous machinery, ensure that dizziness or drowsiness is evaluated after taking this medication. Severe skin reactions may rarely occur, so if symptoms such as skin rash, redness, or blisters appear, immediately inform healthcare personnel and discontinue the medication. In case of overdose, severe drowsiness, confusion, or depression may occur, requiring immediate emergency treatment. Keep out of reach of children and avoid transferring the medication to other containers.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent exposure to air or moisture. Also, avoid places that are too hot or too cold, and maintain it in a temperature range of 15 to 30 degrees Celsius at room temperature.
A hard capsule with a reddish-brown upper part and a white lower part filled with white powder that is white or light yellow.
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pregabalin
Prescription medication
Telcon RF Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.